US Stock MarketDetailed Quotes

NMRA Neumora Therapeutics

Watchlist
  • 11.570
  • -0.310-2.61%
Trading Jul 17 13:04 ET
1.85BMarket Cap-7258P/E (TTM)

Neumora Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
Assets
Current assets
Cash, cash equivalents and short term investments
--422.72M
22.08%453.98M
22.08%453.98M
--509.57M
-1.01%324.2M
-9.13%371.88M
--371.88M
--327.51M
--349.62M
113.18%409.25M
-Cash and cash equivalents
--182.93M
55.24%374.04M
55.24%374.04M
--412.28M
17.10%204.22M
-41.13%240.94M
--240.94M
--174.4M
--291.18M
113.18%409.25M
-Short-term investments
--239.79M
-38.95%79.94M
-38.95%79.94M
--97.28M
-21.64%119.98M
--130.94M
--130.94M
--153.11M
--58.44M
--0
Receivables
--906K
2.18%939K
2.18%939K
--668K
1.54%594K
359.50%919K
--919K
--585K
--269K
35.14%200K
-Other receivables
--906K
2.18%939K
2.18%939K
--668K
1.54%594K
359.50%919K
--919K
--585K
--269K
35.14%200K
Prepaid assets
--19.16M
54.67%23.36M
54.67%23.36M
--15.5M
-3.44%11.82M
150.41%15.1M
--15.1M
--12.24M
--12.98M
279.07%6.03M
Restricted cash
----
--0
--0
--0
--0
-60.00%50K
--50K
--50K
--50K
0.00%125K
Total current assets
--442.79M
23.28%478.28M
23.28%478.28M
--525.74M
-1.11%336.61M
-6.65%387.96M
--387.96M
--340.39M
--362.92M
114.40%415.6M
Non current assets
Net PPE
--5.91M
-35.56%6.86M
-35.56%6.86M
--7.89M
-10.47%8.68M
163.35%10.64M
--10.64M
--9.7M
--3.8M
3.03%4.04M
-Gross PPE
--5.91M
-29.13%8.29M
-29.13%8.29M
--7.89M
-10.47%8.68M
152.25%11.7M
--11.7M
--9.7M
--3.8M
15.20%4.64M
-Accumulated depreciation
----
-35.38%-1.44M
-35.38%-1.44M
----
----
-77.26%-1.06M
---1.06M
----
----
-469.52%-598K
Investments and advances
--302K
-58.13%9.85M
-58.13%9.85M
--9.91M
5.58%9.89M
--23.51M
--23.51M
--9.37M
--13.81M
--0
Non current deferred assets
----
----
----
----
----
----
----
--2.76M
--2.15M
--1.83M
Non current prepaid assets
----
----
----
----
----
----
----
--0
--0
--7.62M
Other non current assets
--1.21M
-70.60%1.21M
-70.60%1.21M
--1.21M
250.18%4.77M
1,952.74%4.13M
--4.13M
--1.36M
--151K
9.84%201K
Total non current assets
--7.43M
-53.20%17.92M
-53.20%17.92M
--19.01M
0.64%23.34M
179.53%38.28M
--38.28M
--23.19M
--19.91M
233.59%13.69M
Total assets
--450.21M
16.41%496.2M
16.41%496.2M
--544.75M
-1.00%359.95M
-0.71%426.23M
--426.23M
--363.58M
--382.84M
116.88%429.3M
Liabilities
Current liabilities
Payables
--1.49M
-95.28%337K
-95.28%337K
--2.23M
171.04%8.17M
336.06%7.15M
--7.15M
--3.02M
--1.65M
-31.65%1.64M
-accounts payable
--1.49M
-95.28%337K
-95.28%337K
--2.23M
171.04%8.17M
336.06%7.15M
--7.15M
--3.02M
--1.65M
-31.65%1.64M
Current accrued expenses
--14.83M
258.61%11.25M
258.61%11.25M
--13.77M
-25.32%7.64M
-74.81%3.14M
--3.14M
--10.24M
--10.98M
498.27%12.45M
Current debt and capital lease obligation
--3.49M
0.24%3.38M
0.24%3.38M
--3.4M
28.25%3.32M
219.13%3.37M
--3.37M
--2.59M
--1.04M
38.22%1.06M
-Current capital lease obligation
--3.49M
0.24%3.38M
0.24%3.38M
--3.4M
28.25%3.32M
219.13%3.37M
--3.37M
--2.59M
--1.04M
38.22%1.06M
Other current liabilities
--133K
-91.55%139K
-91.55%139K
--149K
-91.96%158K
10.56%1.64M
--1.64M
--1.97M
--828K
142.97%1.49M
Current liabilities
--24.61M
5.97%25.11M
5.97%25.11M
--29.12M
14.11%26.09M
1.80%23.7M
--23.7M
--22.86M
--17.93M
148.43%23.28M
Non current liabilities
Long term debt and capital lease obligation
--938K
-63.47%1.85M
-63.47%1.85M
--2.75M
-26.99%3.5M
409.24%5.07M
--5.07M
--4.79M
--723K
-22.25%996K
-Long term capital lease obligation
--938K
-63.47%1.85M
-63.47%1.85M
--2.75M
-26.99%3.5M
409.24%5.07M
--5.07M
--4.79M
--723K
-22.25%996K
Preferred securities outside stock equity
----
--0
--0
--0
15.60%843.69M
15.60%843.69M
--843.69M
--729.86M
--729.86M
159.11%729.86M
Other non current liabilities
--122K
-75.32%155K
-75.32%155K
--188K
-71.67%221K
62.69%628K
--628K
--780K
--346K
--386K
Total non current liabilities
--1.06M
-99.76%2.01M
-99.76%2.01M
--2.93M
15.23%847.41M
16.16%849.39M
--849.39M
--735.43M
--730.93M
158.43%731.24M
Total liabilities
--25.67M
-96.89%27.12M
-96.89%27.12M
--32.06M
15.19%873.49M
15.71%873.08M
--873.08M
--758.29M
--748.85M
158.10%754.52M
Shareholders'equity
Share capital
--16K
433.33%16K
433.33%16K
--15K
-80.00%3K
0.00%3K
--3K
--15K
--15K
-76.92%3K
-common stock
--16K
433.33%16K
433.33%16K
--15K
-80.00%3K
0.00%3K
--3K
--15K
--15K
-76.92%3K
Retained earnings
---757.16M
-50.46%-703.43M
-50.46%-703.43M
---594.7M
-32.11%-541.68M
-38.89%-467.51M
---467.51M
---410.02M
---379.65M
-239.00%-336.61M
Paid-in capital
--1.18B
5,371.63%1.17B
5,371.63%1.17B
--1.11B
76.80%28.58M
88.30%21.43M
--21.43M
--16.17M
--13.79M
132.46%11.38M
Gains losses not affecting retained earnings
---148K
90.18%-76K
90.18%-76K
---311K
48.51%-448K
---774K
---774K
---870K
---178K
--0
Total stockholders'equity
--424.54M
204.97%469.08M
204.97%469.08M
--512.69M
-30.11%-513.54M
-37.40%-446.85M
---446.85M
---394.71M
---366.02M
-244.57%-325.22M
Total equity
--424.54M
204.97%469.08M
204.97%469.08M
--512.69M
-30.11%-513.54M
-37.40%-446.85M
---446.85M
---394.71M
---366.02M
-244.57%-325.22M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021
Assets
Current assets
Cash, cash equivalents and short term investments --422.72M22.08%453.98M22.08%453.98M--509.57M-1.01%324.2M-9.13%371.88M--371.88M--327.51M--349.62M113.18%409.25M
-Cash and cash equivalents --182.93M55.24%374.04M55.24%374.04M--412.28M17.10%204.22M-41.13%240.94M--240.94M--174.4M--291.18M113.18%409.25M
-Short-term investments --239.79M-38.95%79.94M-38.95%79.94M--97.28M-21.64%119.98M--130.94M--130.94M--153.11M--58.44M--0
Receivables --906K2.18%939K2.18%939K--668K1.54%594K359.50%919K--919K--585K--269K35.14%200K
-Other receivables --906K2.18%939K2.18%939K--668K1.54%594K359.50%919K--919K--585K--269K35.14%200K
Prepaid assets --19.16M54.67%23.36M54.67%23.36M--15.5M-3.44%11.82M150.41%15.1M--15.1M--12.24M--12.98M279.07%6.03M
Restricted cash ------0--0--0--0-60.00%50K--50K--50K--50K0.00%125K
Total current assets --442.79M23.28%478.28M23.28%478.28M--525.74M-1.11%336.61M-6.65%387.96M--387.96M--340.39M--362.92M114.40%415.6M
Non current assets
Net PPE --5.91M-35.56%6.86M-35.56%6.86M--7.89M-10.47%8.68M163.35%10.64M--10.64M--9.7M--3.8M3.03%4.04M
-Gross PPE --5.91M-29.13%8.29M-29.13%8.29M--7.89M-10.47%8.68M152.25%11.7M--11.7M--9.7M--3.8M15.20%4.64M
-Accumulated depreciation -----35.38%-1.44M-35.38%-1.44M---------77.26%-1.06M---1.06M---------469.52%-598K
Investments and advances --302K-58.13%9.85M-58.13%9.85M--9.91M5.58%9.89M--23.51M--23.51M--9.37M--13.81M--0
Non current deferred assets ------------------------------2.76M--2.15M--1.83M
Non current prepaid assets ------------------------------0--0--7.62M
Other non current assets --1.21M-70.60%1.21M-70.60%1.21M--1.21M250.18%4.77M1,952.74%4.13M--4.13M--1.36M--151K9.84%201K
Total non current assets --7.43M-53.20%17.92M-53.20%17.92M--19.01M0.64%23.34M179.53%38.28M--38.28M--23.19M--19.91M233.59%13.69M
Total assets --450.21M16.41%496.2M16.41%496.2M--544.75M-1.00%359.95M-0.71%426.23M--426.23M--363.58M--382.84M116.88%429.3M
Liabilities
Current liabilities
Payables --1.49M-95.28%337K-95.28%337K--2.23M171.04%8.17M336.06%7.15M--7.15M--3.02M--1.65M-31.65%1.64M
-accounts payable --1.49M-95.28%337K-95.28%337K--2.23M171.04%8.17M336.06%7.15M--7.15M--3.02M--1.65M-31.65%1.64M
Current accrued expenses --14.83M258.61%11.25M258.61%11.25M--13.77M-25.32%7.64M-74.81%3.14M--3.14M--10.24M--10.98M498.27%12.45M
Current debt and capital lease obligation --3.49M0.24%3.38M0.24%3.38M--3.4M28.25%3.32M219.13%3.37M--3.37M--2.59M--1.04M38.22%1.06M
-Current capital lease obligation --3.49M0.24%3.38M0.24%3.38M--3.4M28.25%3.32M219.13%3.37M--3.37M--2.59M--1.04M38.22%1.06M
Other current liabilities --133K-91.55%139K-91.55%139K--149K-91.96%158K10.56%1.64M--1.64M--1.97M--828K142.97%1.49M
Current liabilities --24.61M5.97%25.11M5.97%25.11M--29.12M14.11%26.09M1.80%23.7M--23.7M--22.86M--17.93M148.43%23.28M
Non current liabilities
Long term debt and capital lease obligation --938K-63.47%1.85M-63.47%1.85M--2.75M-26.99%3.5M409.24%5.07M--5.07M--4.79M--723K-22.25%996K
-Long term capital lease obligation --938K-63.47%1.85M-63.47%1.85M--2.75M-26.99%3.5M409.24%5.07M--5.07M--4.79M--723K-22.25%996K
Preferred securities outside stock equity ------0--0--015.60%843.69M15.60%843.69M--843.69M--729.86M--729.86M159.11%729.86M
Other non current liabilities --122K-75.32%155K-75.32%155K--188K-71.67%221K62.69%628K--628K--780K--346K--386K
Total non current liabilities --1.06M-99.76%2.01M-99.76%2.01M--2.93M15.23%847.41M16.16%849.39M--849.39M--735.43M--730.93M158.43%731.24M
Total liabilities --25.67M-96.89%27.12M-96.89%27.12M--32.06M15.19%873.49M15.71%873.08M--873.08M--758.29M--748.85M158.10%754.52M
Shareholders'equity
Share capital --16K433.33%16K433.33%16K--15K-80.00%3K0.00%3K--3K--15K--15K-76.92%3K
-common stock --16K433.33%16K433.33%16K--15K-80.00%3K0.00%3K--3K--15K--15K-76.92%3K
Retained earnings ---757.16M-50.46%-703.43M-50.46%-703.43M---594.7M-32.11%-541.68M-38.89%-467.51M---467.51M---410.02M---379.65M-239.00%-336.61M
Paid-in capital --1.18B5,371.63%1.17B5,371.63%1.17B--1.11B76.80%28.58M88.30%21.43M--21.43M--16.17M--13.79M132.46%11.38M
Gains losses not affecting retained earnings ---148K90.18%-76K90.18%-76K---311K48.51%-448K---774K---774K---870K---178K--0
Total stockholders'equity --424.54M204.97%469.08M204.97%469.08M--512.69M-30.11%-513.54M-37.40%-446.85M---446.85M---394.71M---366.02M-244.57%-325.22M
Total equity --424.54M204.97%469.08M204.97%469.08M--512.69M-30.11%-513.54M-37.40%-446.85M---446.85M---394.71M---366.02M-244.57%-325.22M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg